5DK3

Crystal Structure of Pembrolizumab, a full length IgG4 antibody


Sequence Similarity Clusters for the Entities in PDB 5DK3

Entity #1 | Chains: A,F
Light Chain protein, length: 218 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 3 19567
95 % 2 3 18259
90 % 96 309 49
70 % 893 2724 2
50 % 2319 7028 1
40 % 2326 7045 1
30 % 2342 7092 1
Entity #2 | Chains: B,G
Heavy Chain protein, length: 444 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 49906
95 % 1 1 45128
90 % 1 1 42917
70 % 3 10 4811
50 % 4 27 1463
40 % 4 33 1095
30 % 4 33 1157

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6VI2 1 A, C FAB4 light chain 9606
2 6VI2 2 B, D FAB4 heavy chain 9606
3 4NZU 1 L 13PL heavy chain Fab 9606
4 4NZU 2 H 13PL light chain Fab 9606
5 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
6 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
7 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
8 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
9 1MEX 1 L Fab 29G12 light chain 10090
10 1MEX 2 H Fab 29G12 heavy chain 10090
11 6WFY 1 H Fab224 heavy chain 9606
12 6WFY 2 L Fab224 light chain 9606
13 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
14 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
15 4BUH 1 A, B CLONE M0418 SCFV 9606
16 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
17 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
18 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
19 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
20 6UCF 1 L N123-VRC34_pI4 light chain 9606
21 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
22 5YD4 1 A, C, E, G scFv 4B08 10090
23 5YD3 1 A, C, E, G scFv 4B08 10090
24 6OC7 1 H Heavy chain of HMP42 Fab 9606
25 6OC7 2 L Light chain for HMP42 Fab 9606
26 5UD9 1 H Fab heavy chain 9606
27 5UD9 2 L Light chain 9606
28 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
29 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
30 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
31 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
32 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
33 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
34 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
35 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
36 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
37 6MEE 2 B, D antibody HEPC74 Light Chain 9606
38 6BJZ 1 H 5c8 Fab Heavy chain 9606
39 6BJZ 2 L 5c8 Fab Light chain 9606
40 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
41 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
42 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
43 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
44 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
45 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
46 4XCF 1 L 4E10 Fab light chain 9606
47 4XCF 2 H 4E10 Fab heavy chain 9606
48 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
49 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
50 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
51 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
52 6O24 1 A 4498 Fab heavy chain 9606
53 6O24 2 B 4498 Kappa light chain 9606
54 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
55 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
56 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
57 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
58 6UCE 1 L N123-VRC34_pI3 light chain 9606
59 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
60 6Y1L 1 H FAB A.17 L47R mutant HEAVY CHAIN 9606
61 6Y1L 2 L FAB A.17 L47R mutant Light CHAIN 9606
62 5X08 1 H Fab 4E10 Heavy chain 9606
63 5X08 2 L Fab 4E10 Light chain 9606
64 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
65 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
66 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
67 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
68 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
69 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
70 6MEG 1 H antibody HEPC46 Heavy Chain 9606
71 6MEG 2 L antibody HEPC46 Light Chain 9606
72 5C2B 1 H scFv 3B4 9606
73 6O3K 1 L PGZL1.H4K3 light chain 9606
74 6O3K 2 H PGZL1.H4K3 heavy chain 9606
75 4XAW 1 L 4E10 Fab light chain 9606
76 4XAW 2 H 4E10 Fab heavy chain 9606
77 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
78 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
79 6WG8 1 A Dupilumab Fab heavy chain 9606
80 6WG8 2 B Dupilumab Fab light chain 9606
81 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
82 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
83 7K3Q 1 H Fab fragment of S2E12 monoclonal antibody, heavy chain 9606
84 7K3Q 2 L Fab fragment of S2E12 monoclonal antibody, light chain 9606
85 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
86 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
87 5UCB 1 H Fab Heavy Chain 9606
88 5UCB 2 L Fab Light Chain 9606
89 2VXV 1 H HUMAN IGG ABT-325 9606
90 2VXV 2 L HUMAN IGG ABT-325 9606
91 6QF9 1 A, B scFv 9606
92 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
93 4GXV 1 H, I Antibody 1F1, heavy chain 9606
94 4GXV 2 L, M Antibody 1F1, light chain 9606
95 2VXT 1 H MURINE IGG 125-2H 10090
96 2VXT 3 L MURINE IGG 125-2H 10090
97 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
98 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
99 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
100 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
101 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
102 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
103 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
104 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
105 5W24 1 L 5C4 Fab Light Chain 10090
106 5W24 2 H 5C4 Fab Heavy Chain 10090
107 4HPY 1 H CH59 Fab heavy chain 9606
108 4HPY 2 L CH59 Fab light chain 9606
109 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
110 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
111 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
112 6XMI 1 A, D Fab Light chain 9606
113 6XMI 2 B, E Fab Heavy chain 9606
114 4JG1 1 L Fab light chain 9606
115 4JG1 2 H Fab heavy chain 9606
116 6E65 1 L TB31F Fab light chain 9606
117 6E65 2 H TB31F Fab heavy chain 9606
118 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
119 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
120 5VF2 1 A scFv 2D10 10090
121 5I8C 1 A VRC34.01 Fab heavy chain 9606
122 5I8C 2 B VRC34.01 Fab light chain 9606
123 4O5L 1 L Fab F045-092 light chain 9606
124 4O5L 2 H Fab F045-092 heavy chain 9606
125 5MYX 1 A, C Fab c#24 light chain 10090
126 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
127 3IFL 1 L 12A11 FAB antibody light chain 10090
128 3IFL 2 H 12A11 FAB antibody heavy chain 10090
129 5WK2 1 L M116 LIGHT CHAIN 9606
130 5WK2 2 H M116 HEAVY CHAIN FD 9606
131 3PP4 1 H GA101 Fab heavy chain 10090
132 3PP4 2 L GA101 Fab light chain 10090
133 3KDM 1 A, L Immunoglobulin light chain 9606
134 3KDM 2 B, H Immunoglobulin heavy chain 9606
135 5NIV 1 A Light chain of 5D3 Fab 10090
136 5NIV 2 B Heavy chain of 5D3 Fab 10090
137 6UG7 1 L ch28/11 Fab light chain 10090
138 6UG7 2 H ch28/11 Fab heavy chain 10090
139 5N4J 1 L LIGHT CHAIN 9606
140 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
141 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
142 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
143 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
144 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
145 5X4G 1 A 6H8 Fab heavy chain 10090
146 5X4G 2 B 6H8 Fab light chain 10090
147 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
148 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
149 4PTU 1 A Antibody pn132p2C05, light chain 9606
150 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
151 4TPR 1 L If kappa light chain 10090
152 4TPR 2 H Fab heavy chain 10090
153 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
154 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
155 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
156 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
157 3IFN 1 H 12A11 FAB antibody heavy chain 10090
158 3IFN 2 L 12A11 FAB antibody light chain 10090
159 5U3P 1 H DH511.4 Fab Heavy Chain 9606
160 5U3P 2 L DH511.4 Fab Light Chain 9606
161 6BLA 1 H AMM01 Fab Heavy chain 9606
162 6BLA 2 L AMM01 Fab Light chain 9606
163 4TOY 1 H 35O22 Fab Heavy chain 9606
164 4TOY 2 L 35O22 Fab Light chain 9606
165 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
166 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
167 3NPS 2 B S4 FAB HEAVY CHAIN 9606
168 3NPS 3 C S4 FAB LIGHT CHAIN 9606
169 5I4F 1 A scFv 2D10 10090
170 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
171 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
172 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
173 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
174 5WN9 1 H scFv 2D10 9606
175 4XC3 1 L 4E10 Fab light chain 9606
176 4XC3 2 H 4E10 Fab heavy chain 9606
177 4M5Y 1 H, I Fab 5J8 heavy chain 9606
178 4M5Y 2 L, M Fab 5J8 light chain 9606
179 4TQE 1 L If kappa light chain 10090
180 4TQE 2 H Fab heavy chain 10090
181 5YY4 1 A scFv 4B08 10090
182 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
183 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
184 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
185 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
186 6Q19 1 L Fab lambda chain 9606
187 6Q19 2 H Fab heavy chain 9606
188 6PDR 1 L antibody vFP25.18 light chain 10090
189 6PDR 2 H antibody vFP25.18 heavy chain 10090
190 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
191 5VSI 2 L CH1/Ckappa Fab light chain 9606
192 6NUY 1 L antibody M86 Fab arm light chain 10090
193 6NUY 2 H antibody M86 Fab arm heavy chain 10090
194 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
195 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
196 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
197 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
198 5JXA 1 H VRC03 Heavy chain 9606
199 5JXA 2 L VRC03 Light chain 9606
200 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
201 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
202 6QCU 1 L Light chain 9606
203 6QCU 2 H Heavy chain 9606
204 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
205 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
206 3NTC 1 L Fab light chain 10090
207 3NTC 2 H Fab heavy chain 10090
208 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
209 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
210 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
211 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
212 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
213 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
214 6PBV 1 A, C Fab668 light chain 9606
215 6PBV 2 B, D Fab668 heavy chain 9606
216 6PZG 1 L NA-80 Fab light chain 9606
217 6PZG 2 H NA-80 Fab heavy chain 9606
218 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
219 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
220 6BE3 1 H Fab (F598) Heavy Chain 9606
221 6BE3 2 L Fab (F598) Light Chain 9606
222 4NWU 1 H APE1551 Ab Fab heavy chain 9606
223 4NWU 2 L APE1551 Ab Fab light chain 9606
224 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
225 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
226 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
227 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
228 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
229 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
230 5EWI 1 H VRC38.01 Heavy Chain 9606
231 5EWI 2 L VRC38.01 Light Chain 9606
232 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
233 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
234 5E2W 1 L AT8 LIGHT CHAIN 10090
235 5E2W 2 H AT8 HEAVY CHAIN 10090
236 5MYK 1 A Fab c#17 light chain 10090
237 5MYK 2 B Fab c#17 heavy chain 10090
238 4NZR 1 H PGT135 heavy chain Fab 9606
239 4NZR 2 L PGT135 light chain Fab 9606
240 5MYO 1 A, C Fab c#6 light chain 10090
241 5MYO 2 B, D Fab c#6 heavy chain 10090
242 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
243 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
244 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
245 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
246 5UEL 1 H 354NC102 Fab Heavy Chain 9606
247 5UEL 2 L 354NC102 Fab Light Chain 9606
248 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
249 6WIY 1 H Fab 54-1G05 heavy chain 9606
250 6WIY 2 L Fab 54-1G05 light chain 9606
251 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
252 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
253 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
254 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
255 5E2V 1 L AT8 LIGHT CHAIN 10090
256 5E2V 2 H AT8 HEAVY CHAIN 10090
257 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
258 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
259 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
260 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
261 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
262 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
263 5JUE 1 L light chain of UIC2 Fab 10090
264 5JUE 2 H heavy chain of UIC2 Fab 10090
265 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
266 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
267 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
268 5JR1 1 H 10E8 heavy chain 9606
269 5JR1 2 L 10E8 mature light chain 9606
270 6CA7 1 L PCT64_13C light chain 9606
271 6CA7 2 H PCT64_13C heavy chain 9606
272 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
273 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
274 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
275 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
276 6MVL 2 H Antibody Fab fragment heavy chain 9606
277 6MVL 3 L Antibody Fab fragment light chain 9606
278 5OB5 2 H fAb Heavy chain 9606
279 5OB5 3 L fAb Light chain 9606
280 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
281 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
282 5I66 1 A 8B6 antibody, heavy chain 10090
283 5I66 2 B 8B6 antibody, light chain 10090
284 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
285 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
286 6WG0 1 H Fab366 heavy chain 9606
287 6WG0 2 L Fab366 light chain 9606
288 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
289 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
290 6BZY 1 H 22D11 Heavy Chain 10090
291 6BZY 2 L 22D11 Light Chain 10090
292 3QQ9 1 C, L 101F LIGHT CHAIN 10090
293 3QQ9 2 D, H 101F HEAVY CHAIN 10090
294 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
295 5TKK 3 L mouse antibody vFP5.01 light chain 10090
296 6PLH 1 A Fab 5G12 light chain 10090
297 6PLH 2 B Fab 5G12 heavy chain 10090
298 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
299 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
300 5W6C 1 H UCA Fab heavy chain 9606
301 5W6C 2 L UCA Fab light chain 9606
302 5I1K 1 L FAB LIGHT CHAIN 9606
303 5I1K 2 H FAB HEAVY CHAIN 9606
304 3OZ9 1 L Fab NC-1 kappa light chain 10090
305 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
306 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
307 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
308 5V7U 1 L CBTAU-22.1 Fab light chain 9606
309 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
310 5UEA 1 A, H Fab Heavy Chain 9606
311 5UEA 3 B, L Fab Light Chain 9606
312 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
313 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
314 6LTG 1 A, C antibody Fab fragment H-chain 10090
315 6LTG 2 B, D antibody Fab fragment L-chain 10090
316 3G5Y 1 A 175 light chain 10090
317 3G5Y 2 B 175 heavy chain 10090
318 5NMV 1 L Fab light chain 10088
319 5NMV 2 H Fab heavy chain 10088
320 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
321 4N8C 2 L, M Light chain of monoclonal antibody 10090
322 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
323 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
324 4HGW 1 A Antibody Fab fragment, light chain 10090
325 4HGW 2 B Antibody Fab fragment, heavy chain 10090
326 1NLB 1 L antibody 19D9D6 light chain 10090
327 1NLB 2 H antibody 19D9D6 heavy chain 10090
328 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
329 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
330 3VFG 1 L 3F8 Light Chain 10090
331 3VFG 2 H 3F8 Heavy Chain 10090
332 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
333 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
334 3QRG 1 L Fab light chain 9606
335 3QRG 2 H Fab heavy chain Fd fragment 9606
336 5M6A 1 A, B, C, D Bence-Jones light chain 9606
337 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
338 4LLY 2 B, D light chain Clambda 9606
339 6Y49 1 H A.17kappa antibody FAB fragment - Heavy Chain 9606
340 6Y49 2 L A.17kappa antibody FAB fragment - Light Chain 9606
341 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
342 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
343 5EZI 1 H Fab c12 heavy chain 9606
344 5EZI 2 L Fab c12 Light chain 9606
345 4K23 1 H anti-uPAR antibody, heavy chain 10090
346 4K23 2 L anti-uPAR antibody, light chain 10090
347 3NCJ 1 L Fab15 Mut8 light chain 9606
348 3NCJ 2 H Fab15 Mut8 heavy chain 9606
349 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
350 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
351 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
352 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
353 5W05 1 L M59 FAB LIGHT CHAIN 10090
354 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
355 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
356 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
357 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
358 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
359 4M61 1 A, C Fab A52 light chain 10090
360 4M61 2 B, D Fab A52 heavy chain 10090
361 5YE3 1 B 2A7D9 VH CH1 chain 10090
362 5YE3 2 A 2A7D9 L chain 10090
363 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
364 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
365 1UM5 1 L Antibody 21H3 L chain 10090
366 1UM5 2 H Antibody 21H3 H chain 10090
367 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
368 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
369 4NWT 1 L APE1531 Ab Fab light chain 9606
370 4NWT 2 H APE1531 Ab Fab heavy chain 9606
371 3WHX 1 A mAb Fab H fragment 10090
372 3WHX 2 B mAb Fab L fragment 10090
373 3NA9 1 L Fab15 light chain 9606
374 3NA9 2 H Fab15 heavy chain 9606
375 6Y1K 1 H FAB A.17 L47R mutant Heavy Chain 9606
376 6Y1K 2 L FAB A.17 L47R mutant Light Chain 9606
377 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
378 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
379 6RCO 1 A, C R5.004 heavy chain 9606
380 6RCO 2 B, D R5.004 light chain 9606
381 6VBO 1 L DH813 light chain 9606
382 6VBO 2 H DH813 heavy chain 9606
383 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
384 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
385 4LRI 1 A, B MSL-109 Light Chain 9606
386 4LRI 2 C, P MSL-109 Heavy Chain 9606
387 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
388 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
389 4JN2 1 A, L anti dabigatran Fab 10090
390 4JN2 2 B, H anti dabigatran Fab 10090
391 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
392 4XBE 2 H 4E10 Fab heavy chain 9606
393 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
394 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
395 6BE2 1 H Fab (F598) Heavy Chain 9606
396 6BE2 2 L Fab (F598) Light Chain 9606
397 4JFZ 1 L Fab light chain 9606
398 4JFZ 2 H Fab heavy chain 9606
399 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
400 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
401 3WIF 1 A mAb Fab H fragment 10090
402 3WIF 2 B mAb Fab L fragment 10090
403 5U6A 1 A Light Chain 9606
404 5U6A 2 B Heavy Chain 9606
405 6K0Y 1 A Antibody Heavy Chain 9606
406 6K0Y 2 B Antibody Light Chain 9606
407 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
408 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
409 3MBX 1 L X836 LIGHT CHAIN 10090
410 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
411 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
412 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
413 6PXR 1 L BIIB092 Fab (murine), light chain 10090
414 6PXR 2 H BIIB092 Fab (murine), heavy chain 10090
415 6APC 1 H Epididymis luminal protein 214 9606
416 6APC 2 L IGL@ protein 9606
417 6WOS 1 H Fab AR3B heavy chain 9606
418 6WOS 2 L Fab AR3B light chain 9606
419 4HHA 1 A Fab KE5 Fab fragment KE5 9606
420 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
421 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
422 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
423 4RGO 2 H 14G8 heavy chain Fab 10090
424 4RGO 3 L 14G8 light chain Fab 10090
425 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
426 5GRY 1 A, G diabody 9606
427 5UEK 2 H Fab 12E Heavy Chain 9606
428 5UEK 3 L Fab 12E Light Chain 9606
429 7K8N 1 A C102 Fab Heavy Chain 9606
430 7K8N 2 B C102 Fab Light Chain 9606
431 3NAA 1 L Fab15 Mut5 light chain 9606
432 3NAA 2 H Fab15 Mut5 heavy chain 9606
433 1Q0X 1 L Fab 9B1, light chain 10090
434 1Q0X 2 H Fab 9B1, heavy chain 10090
435 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
436 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
437 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
438 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
439 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
440 5IK3 2 B, D 1E03 Fab fragment light chain 9606
441 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
442 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
443 5XLI 1 a, b FabL 10090
444 5XLI 2 c, d FabH 10090
445 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
446 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
447 6DC4 1 H Fab AM22 Heavy Chain 9606
448 6DC4 2 L Fab AM22 Light Chain 9606
449 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
450 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
451 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
452 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
453 4WUK 1 H CH65 heavy chain 9606
454 4WUK 2 L CH65 light chain 9606
455 6WGK 1 A, C, E, G Dupilumab Fab heavy chain 9606
456 6WGK 2 B, D, F, H Dupilumab Fab light chain 9606
457 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
458 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
459 7JMP 2 H COVA2-39 heavy chain 9606
460 7JMP 3 L COVA2-39 light chain 9606
461 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
462 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
463 5JOP 1 D, L Fab 14.22 light chain 10090
464 5JOP 2 E, H Fab14.22 heavy chain 10090
465 4HPO 1 H CH58 Fab heavy chain 9606
466 4HPO 2 L CH58 Fab light chain 9606
467 6VLN 1 H 4498 Fab heavy chain 9606
468 6VLN 2 L 4498 Fab light chain 9606
469 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
470 5UKN 2 L DH522UCA Fab fragment light chain 9544
471 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
472 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
473 5IT2 1 H heavy chain 9606
474 5IT2 2 L light chain 9606
475 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
476 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
477 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
478 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
479 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
480 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
481 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
482 5MO3 3 L Fab of monoclonal antibody, light chain 10090
483 6L8T 1 B, D, L Antibody light chain 9606
484 6L8T 2 A, C, H Antibody heavy chain 9606
485 5GZ0 1 A, C FM329 light chain 1383439
486 5GZ0 2 B, D FM329 heavy chain 1383439
487 6DW2 1 A 6078 Fab light chain 9606
488 6DW2 2 B 6078 Fab heavy chain 9606
489 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
490 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
491 6MG4 1 A, B JTO light chain 9606
492 6BQB 1 L MGG4 Fab light chain 9606
493 6BQB 2 H MGG4 Fab heavy chain 9606
494 4PUB 1 H DX-2930 HEAVY CHAIN 9606
495 4PUB 2 L DX-2930 LIGHT CHAIN 9606
496 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
497 6B14 2 L Light chain of Fab BL3-6S97N 10090
498 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
499 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
500 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
501 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
502 5GS3 1 A, H diabody protein 9606
503 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
504 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
505 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
506 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
507 5VKD 2 H Fab Heavy Chain 9606
508 5VKD 3 L Fab light chain 9606
509 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
510 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
511 5XHG 1 A, C polypeptide(L) 10090
512 5XHG 2 B, D polypeptide(H) 10090
513 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
514 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
515 3UYR 1 H antibody Fab heavy chain 10090
516 3UYR 2 L antibody Fab light chain 10090
517 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
518 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
519 6UOE 1 H 3-25 Fab heavy chain 9606
520 6UOE 2 L 3-25 Fab light chain 9606
521 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
522 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
523 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
524 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
525 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
526 3OAZ 2 K, L Fab 2G12, light chain 9606
527 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
528 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
529 1ZAN 1 L Fab AD11 Light Chain 10116
530 1ZAN 2 H Fab AD11 Heavy Chain 10116
531 6CJK 1 A, C Immunoglobulin Fab light chain 9986
532 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
533 4N0Y 1 H IGH526 Heavy Chain 9606
534 4N0Y 2 L IGH526 Light Chain 9606
535 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
536 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
537 6OTC 2 H sFab H3 heavy chain 32630
538 6OTC 3 L sFab H3 light chain 32630
539 6Q1G 1 L H1244 Fab lambda chain 9606
540 6Q1G 2 H H1244 Fab heavy chain 9606
541 5MTH 1 A, H antibody Fab heavy chain 10090
542 5MTH 2 B, L antibody Fab light chain 10090
543 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
544 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
545 6O26 1 A 3246 Fab heavy chain 9606
546 6O26 2 B 3246 Fab light chain 9606
547 1RZF 1 L Fab E51 light chain 9606
548 1RZF 2 H Fab E51 heavy chain 9606
549 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
550 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
551 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
552 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
553 6WJ0 1 H Fab 54-4H03 heavy chain 9606
554 6WJ0 2 L Fab 54-4H03 light chain 9606
555 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
556 4KTE 2 L GE148 Light Chain Fab 9544
557 5I8O 1 H HMM5 antibody heavy chain 9606
558 5I8O 2 L HMM5 antibody light chain 9606
559 4JG0 1 L Fab light chain 9606
560 4JG0 2 H Fab heavy chain 9606
561 6LKT 1 A antibody Fab fragment H chain 10090
562 6LKT 2 B antibody Fab Fragment L-chain 10090
563 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
564 4YGV 2 B, L aDabi-Fab2a light chain 9606
565 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
566 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
567 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
568 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
569 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
570 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
571 3EO0 1 A, C GC-1008 Fab Light Chain 10090
572 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
573 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
574 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
575 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
576 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
577 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
578 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
579 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
580 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
581 4FQI 3 H antibody CR9114 heavy chain Fab 9606
582 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
583 6KX1 1 A Fab Fragment-SN-101-Heavy chain 10090
584 6KX1 2 B Fab Fragment-SN-101-Light chain 10090
585 6S5A 2 H anti P329G LALA Fab heavy chain 10090
586 6S5A 3 L anti P329G LALA Fab light chain 10090
587 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
588 4JHA 2 L D25 light chain 9606
589 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
590 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
591 6B9Z 1 A Trastuzumab Fab light chain 10090
592 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
593 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
594 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
595 4PTT 1 A Antibody pn132p2C05, light chain 9606
596 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
597 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
598 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
599 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
600 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
601 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
602 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
603 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
604 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
605 6SXI 1 H Fab heavy chain 10090
606 6SXI 2 L Fab light chain 10090
607 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
608 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
609 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
610 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
611 4DGV 1 H HCV1 Heavy Chain Fab 9606
612 4DGV 2 L HCV1 Light Chain 9606
613 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
614 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
615 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
616 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
617 5TH2 1 A, C cetuximab Fab, light chain 10090
618 5TH2 2 B, D cetuximab Fab, heavy chain 10090
619 5I8K 1 L HHH1 Fab Light chain 9606
620 5I8K 2 H HHH1 Fab Heavy chain 9606
621 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
622 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
623 6ULF 1 A 4498 Fab heavy chain 9606
624 6ULF 2 B 4498 Fab light chain 9606
625 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
626 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
627 1YNL 1 L Ig gamma light chain 10090
628 1YNL 2 H Ig gamma heavy chain 10090
629 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
630 5EPM 2 B, F Antibody Fab fragment light chain 10090
631 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
632 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
633 3UMT 1 A scFv heavy chain and light chain 10090
634 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
635 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
636 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
637 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
638 6UC5 1 H Fab397 heavy chain 9606
639 6UC5 2 L Fab397 light chain 9606
640 6PEC 1 L antibody light chain 9544
641 6PEC 2 H antibody heavy chain 9544
642 6VJT 1 H Heavy Chain Fab Fragment of Monoclonal Ab15 9606
643 6VJT 2 L Light Chain Fab Fragment of Monoclonal antibody A15 9606
644 4NUJ 1 A PGT152 light chain 9606
645 4NUJ 2 B PGT152 heavy chain 9606
646 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
647 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
648 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
649 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
650 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
651 3U2S 2 B, L PG9 light chain 9606
652 6PE7 1 H FAB Heavy Chain 9606
653 6PE7 2 L FAB Light chain 9606
654 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
655 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
656 6KS2 1 A, C Fab7881 Light Chain (FabL) 10090
657 6KS2 2 B, D Fab7881 Heavy Chain (FabH) 10090
658 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
659 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
660 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
661 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
662 4NUG 1 L PGT151 light chain 9606
663 4NUG 2 H PGT151 heavy chain 9606
664 7BZ5 2 H Heavy chain of B38 9606
665 7BZ5 3 L Light chain of B38 9606
666 3IU4 1 H chP3 Fab heavy chain 10090
667 3IU4 2 L chP3 Fab light chain 10090
668 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
669 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
670 6WYT 1 H MuSK1B heavy chain Fab 9606
671 6WYT 2 L MuSK1B light chain Fab 9606
672 6DC8 1 L IgG light chain 10090
673 6DC8 2 H IgG heavy chain 10090
674 6NYQ 1 L 1H3 Fab light chain 10090
675 6NYQ 2 H 1H3 Fab heavy chain 10090
676 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
677 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
678 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
679 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
680 6IAS 1 H Fab NKp46-1 heavy chain 32630
681 6IAS 2 L Fab NKp46-1 light chain 32630
682 1P7K 1 A, L antibody light chain FAB 10090
683 1P7K 2 B, H antibody heavy chain FAB 10090
684 6WYR 1 L, M MuSK1A light chain Fab 9606
685 6WYR 2 H, I MuSK1A heavy chain Fab 9606
686 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
687 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
688 3RVV 2 C 4C1 - light chain 10090
689 3RVV 3 D 4C1 - heavy chain 10090
690 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
691 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
692 3P0Y 2 H Fab DL11 heavy chain 9606
693 3P0Y 3 L Fab DL11 light chain 9606
694 4NPY 1 A, L germline PGT121 light chain Fab 9606
695 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
696 6ANA 2 H LL2 Fab Heavy Chain 10090
697 6ANA 3 L LL2 Fab Light Chain 10090
698 5IBU 1 B, L 6652 Light Chain 9606
699 5IBU 2 G, H 6652 Heavy Chain 9606
700 5VPL 2 C 4C1 - LIGHT CHAIN 10090
701 5VPL 3 D 4C1 - HEAVY CHAIN 10090
702 6AOD 1 A FXIa Antibody FAB Light Chain 9606
703 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
704 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
705 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
706 2YPV 2 H FAB 12C1 10090
707 2YPV 3 L FAB 12C1 10090
708 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
709 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
710 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
711 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
712 4JY5 1 L PGT122 light chain Fab 9606
713 4JY5 2 H PGT122 heavy chain Fab 9606
714 6ELE 1 A, H fAB heavy chain 9606
715 6ELE 2 B, L fAB light chain 9606
716 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
717 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
718 6B5R 1 H CIS42 Fab Heavy chain 9606
719 6B5R 2 L CIS42 Fab Light chain 9606
720 3NAC 1 L Fab15 Mut7 light chain 9606
721 3NAC 2 H Fab15 Mut7 heavy chain 9606
722 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
723 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
724 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
725 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
726 1Q72 1 L Fab M82G2, Light chain 10090
727 1Q72 2 H Fab M82G2, Heavy chain 10090
728 6XCA 1 H C105 Heavy Chain 9606
729 6XCA 2 L C105 Light Chain 9606
730 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
731 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
732 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
733 6MNQ 3 L Ab DH727.2 light chain 9544
734 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
735 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
736 4YHO 1 H aDabi-Fab3 heavy chain 9606
737 4YHO 2 L aDabi-Fab3 light chain 9606
738 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
739 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
740 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
741 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
742 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
743 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
744 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
745 4DGY 1 H HCV1 Heavy Chain Fab 9606
746 4DGY 2 L HCV1 Light Chain 9606
747 5EN2 1 A GD01 heavy chain 10090
748 5EN2 2 B GD01 light chain 10090
749 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
750 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
751 6P4Y 1 H 4A10 Fab heavy chain 10090
752 6P4Y 2 L 4A10 Fab light chain 10090
753 3MXW 2 L 5E1 light chain 9606
754 3MXW 3 H 5E1 heavy chain 9606
755 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
756 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
757 3EO9 1 L Efalizumab Fab fragment, light chain 9606
758 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
759 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
760 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
761 6N35 1 K, L Fab 2G12 light chain 9606
762 6N35 2 H, M Fab 2G12 heavy chain 9606
763 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
764 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
765 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
766 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
767 5WUV 1 L light chain 9606
768 5WUV 2 H heavy chain 9606
769 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
770 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
771 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
772 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
773 4JM4 1 H PGT 135 Heavy Chain Fab 9606
774 4JM4 2 L PGT 135 Light Chain Fab 9606
775 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
776 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
777 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
778 5YE4 2 B, D 1A9D7 L chain 10090
779 6B0G 1 C 1245 Antibody, Light Chain 9606
780 6B0G 2 D 1245 Antibody, Heavy Chain 9606
781 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
782 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
783 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
784 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
785 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
786 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
787 6D0X 1 A 2140 Antibody, heavy chain 9606
788 6D0X 2 B 1210 Antibody, light chain 9606
789 6UUD 1 H 5D5 Antibody Fab, heavy chain 10090
790 6UUD 2 L 5D5 Antibody Fab, light chain 10090
791 6BE4 1 H Fab (F598) Heavy Chain 9606
792 6BE4 2 L Fab(F598) Light Chain 9606
793 5TPP 1 L DH270.5 Fab heavy chain 9606
794 5TPP 2 H DH270.5 Fab light chain 9606
795 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
796 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
797 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
798 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
799 6P7H 1 B Antibody DF2F-b.04 light chain 9479
800 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
801 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
802 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
803 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
804 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
805 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
806 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
807 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
808 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
809 5TL5 1 L M2177 LIGHT CHAIN 10090
810 5TL5 2 H M2177 HEAVY CHAIN 10090
811 2FX7 1 L Fab 4E10 Light Chain 9606
812 2FX7 2 H Fab 4E10 Heavy Chain 9606
813 6O39 1 A Antibody F2.I Fab, Light chain 9606
814 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
815 5Y9K 1 L belimumab light chain 9606
816 5Y9K 2 H belimumab heavy chain 9606
817 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
818 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
819 7K8P 1 H C110 Fab Heavy Chain 9606
820 7K8P 2 L C110 Fab Light Chain 9606
821 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
822 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
823 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
824 6GLW 3 D, L Fab 1D11 - Light chain 9844
825 3WFH 1 A mAb Fab H fragment 10090
826 3WFH 2 B mAb Fab L fragment 10090
827 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
828 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
829 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
830 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
831 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
832 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
833 6WFZ 1 A, H Fab399 heavy chain 9606
834 6WFZ 2 B, L Fab399 light chain 9606
835 6GKU 2 H Fab 6F5 - Heavy Chain 9844
836 6GKU 3 L Fab 6F5 - Light chain 9844
837 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
838 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
839 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
840 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
841 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
842 5HI4 3 D, L CAT-2000 FAB light chain 9606
843 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
844 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
845 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
846 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
847 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
848 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
849 3RVW 2 C 4C1 - light chain 10090
850 3RVW 3 D 4C1 - heavy chain 10090
851 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
852 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
853 5XKU 2 B HNIgGA6 light chain 9606
854 5XKU 3 C HNIgGA6 heavy chain 9606
855 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
856 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
857 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
858 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
859 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
860 5HI5 3 D, L CAT-2000 light chain 9606
861 5JO5 1 A, C, E, H 10E8 gHV 9606
862 5JO5 2 B, D, F, L 10E8 gLV 9606
863 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
864 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
865 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
866 5CCK 2 L Antibody 3BC315 Fab light chain 9606
867 6GXX 1 H FAB 1D9 heavy chain 10090
868 6GXX 2 L FAB 1D9 light chain 10090
869 6JP7 1 H immunoglobulin Fab heavy chain 9606
870 6JP7 2 L immunoglobulin Fab light chain 9606
871 5I76 1 A, C FM318_light_chain 1383439
872 5I76 2 B, D FM318_heavy_cahin 1383439
873 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
874 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
875 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
876 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
877 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
878 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
879 5I18 1 L FAB LIGHT CHAIN 9606
880 5I18 2 H FAB HEAVY CHAIN 9606
881 6QB3 2 X scFv55 9606
882 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
883 4JN1 2 L anti-dabigatran Fab1, light chain 10090
884 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
885 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
886 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
887 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
888 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
889 4G5Z 2 L canakinumab antibody fragment light chain 9606
890 6W00 2 L Fab239 light chain 9606
891 6W00 3 H Fab239 heavy chain 9606
892 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
893 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
894 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
895 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
896 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
897 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
898 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
899 2OK0 2 L Fab ED10 light chain 10090
900 2OK0 3 H Fab ED10 heavy chain 10090
901 6P4C 1 L HyHEL10 Fab light chain 10090
902 6P4C 2 H HyHEL10 Fab heavy chain 10090
903 3SOB 1 L antibody light chain 9606
904 3SOB 3 H antibody heavy chain 9606
905 6UG8 1 L ch28/11 Fab light chain 10090
906 6UG8 2 H ch28/11 Fab heavy chain 10090
907 6B5M 1 H CIS43 Fab Heavy chain 9606
908 6B5M 2 L CIS43 Fab Light chain 9606
909 5AWN 1 H Heavy chain of 3BC176 Fab 9606
910 5AWN 2 L Light chain of 3BC176 Fab 9606
911 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
912 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
913 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
914 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
915 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
916 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
917 5DR5 2 L AbD09097 Fab light chain 9606
918 6MG5 1 A, B Light chain JTO 9606
919 2IH3 1 A FAB Heavy Chain 10090
920 2IH3 2 B FAB Light Chain 10090
921 4KQ3 1 L CNTO3186 light chain Fab 9606
922 4KQ3 2 H CNTO3186 heavy chain Fab 9606
923 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
924 6AQ7 3 L POM6 FAB light CHAIN 10090
925 4JFX 1 A, L Fab light chain 9606
926 4JFX 2 B, H Fab heavy chain 9606
927 3SGE 1 I, L Light Chain 10090
928 3SGE 2 H, J Heavy Chain 10090
929 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
930 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
931 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
932 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
933 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
934 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
935 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
936 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
937 5FHB 1 H Antibody 100 Fab heavy chain 9606
938 5FHB 2 L Antibody 100 Fab light chain 9606
939 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
940 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
941 1JGU 1 L Antibody Light Chain 10090
942 1JGU 2 H Antibody Heavy Chain 10090
943 4I77 1 H Lebrikizumab heavy chain Fab 9606
944 4I77 2 L Lebrikizumab light chain Fab 9606
945 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
946 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
947 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
948 4O4Y 2 H 2095-2 heavy chain 9986
949 5OBF 1 H fAb Heavy chain 10090
950 5OBF 2 L fAb Light chain